Henry J. Fuchs - Aug 10, 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
President, Worldwide R&D
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Aug 10, 2023
Transactions value $
-$1,085,111
Form type
4
Date filed
8/11/2023, 01:59 PM
Previous filing
Mar 17, 2023
Next filing
Dec 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale -$1.09M -12K -6.38% $90.43 176K Aug 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in column 4 is the weighted average price. The price actually received ranged from $90.40 to $90.515. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.